8-K

Company

Altimmune, Inc.

Filed

March 5, 2026

Period of Report

March 5, 2026

Accession Number

0001326190-26-000013

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →